Oct. 29, 2022
CH7057288: Chugai's Oral Pan-TRK Inhibitor
CH7057288
oral pan-TRK inhibitor tumor regression NIH3T3/NTRK1 mice models from in-house library screening and SBDD J. Med. Chem., Sep 6, 2022 Chugai Pharmaceutical, Shizuoka, JP
oral pan-TRK inhibitor tumor regression NIH3T3/NTRK1 mice models from in-house library screening and SBDD J. Med. Chem., Sep 6, 2022 Chugai Pharmaceutical, Shizuoka, JP